Why people refuse generic substitution: a population survey of public opinion on generic substitution in Finland

Heikkilä, Reeta; Mäntyselkä, Pekka; Ahonen, Riitta

doi:10.1007/bf03262117

Cited by 5 publications

(12 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, studies of GS have been limited to some particular perspective. For example, several studies in different countries have investigated pharmacists' and patients' opinions regarding GS and the implementation of GS in practice . Some studies on physicians' attitudes and experiences with GS are also available; for example, in Finland, Denmark and Sweden .…”

Section: Introductionmentioning

confidence: 99%

Generic substitution in Finland: lessons learned during 2003-2008

Timonen

Heikkilä

Ahonen

2013

Journal of Pharmaceutical Health Services Research

Self Cite

View full text Add to dashboard Cite

Objectives Obligatory generic substitution (GS) was introduced in Finland in 2003 with the aim of containing medicine costs. In this article The materialized impacts of GS are compared with the impacts that were anticipated before GS was introduced. The implementation of GS in Finland is described from the perspectives of generated savings, patients, physicians and the pharmaceutical distribution chain during the years [2003][2004][2005][2006][2007][2008]. Methods The studies in this research project were done between 2003 and 2008. Data were collected by means of questionnaires, interviews and register-based studies. Data from the Social Insurance Institution of Finland regarding GS are also included in this article. Key findings Obligatory GS has been a successful pharmaceutical policy reform in Finland, and it has been quite effectively implemented in practice. GS has generated significant savings in the cost of medicines through substitution and price competition. Finnish patients and physicians have accepted it. GS has also had many anticipated impacts on the parties involved in the pharmaceutical distribution chain. However, some of the anticipated effects, such as medicine availability problems, have not materialized. Conclusions Implementation of pharmaceutical policy reforms should always be evaluated from different perspectives and at the beginning of the reform and several years after it has been introduced.

show abstract

Section: Introductionmentioning

confidence: 99%

Generic substitution in Finland: lessons learned during 2003-2008

Timonen

Heikkilä

Ahonen

2013

Journal of Pharmaceutical Health Services Research

Self Cite

View full text Add to dashboard Cite

show abstract

“…14 Moreover, according to a Finnish study by R. Heikkila¨et al (2012) the main reason behind patients' refusal to substitute was that the price difference between original and generic drugs was too small. 42 On the other hand, Poland's pharmaceutical market is dominated by expensive branded generics, and savings can only be made when generics cost less.…”

Section: Predictors Of Generic Substitutionmentioning

confidence: 99%

Predictors of generic substitution: The role of psychological, sociodemographic, and contextual factors

Drozdowska

Hermanowski

2016

Research in Social and Administrative Pharmacy

View full text Add to dashboard Cite

“…Note: Heikkilä et al conducted a large study and the findings were published in three papers [48][49][50]. Abbreviations: AeD, antiepileptic drug; OTC, over-the-counter.…”

mentioning

confidence: 95%

“…As a result, their inclination or preference for brand medicines can influence their patients' choice of medicines and hence could be a barrier to use of generic medicines. 30,34,38,41,46,50 For example, in one study, lack of prescribing of generic medicines by physicians was the main reason cited for patients not using them. 38 In New Zealand, the top reason given for not changing a brand of medicine was the recommendation of physicians and pharmacists.…”

mentioning

confidence: 96%

“…Physicians and health care professionals could play a major role in the promotion of generic medicines and hence help in containing medicine costs. 50 Rozano Suplet et al 51 conducted a survey in northern Spain, to evaluate consumers' perceived risks when using or buying generic medicines in Spain. In this study, the risk dimensions were performance risk, physical risk, social risk, psychological risk, and financial risk, and their relationship with the overall risk of use of generic medicines.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Patient knowledge, perceptions, and acceptance of generic medicines: a comprehensive review of the current literature

Alrasheedy¹,

Hassali²,

Stewart³

et al. 2014

View full text Add to dashboard Cite

Background: Generic medicines have the same quality, safety, and efficacy as their counterpart original brand medicines. Generic medicines provide the same therapeutic outcomes but at a much cheaper cost, so are promoted in many countries to contain pharmaceutical expenditure and sustain the health care system. Thus, the perspective of patients and medicine consumers as end users of these medicines is an important factor to enhance the use and utilization of generic medicines. The objective of this paper is to review patients' and consumers' knowledge, perceptions, acceptance, and views of generic medicines in the current literature. Methods: An extensive literature search was performed in several databases, namely Scopus, PubMed, ISI Web of Knowledge, Proquest, and the Wiley online library, to identify relevant studies published in the English literature for the period 1990-2013. Results: A total of 53 studies were included in the review, comprising 24 studies from Europe, ten from North America, six from Asia, five from Australia and New Zealand, five from the Middle East, one from Africa, one from Latin America, and one from the Caribbean region. A large body of literature has reported misconceptions and negative perceptions about generic medicines on the part of patients and medicine consumers. Moreover, although it is reported in almost all countries, the percentage of consumers who had such misconceptions varied from one country to another. However, in many countries, there was a meaningful percentage of patients who had negative perceptions and misconceptions about generic medicines. Moreover, such misconceptions and negative perceptions were reported as major obstacles to the use and acceptance of generic medicines among patients. Further, studies that focused on specific populations (eg, patients with epilepsy, psychosis, or renal disease) reported a more negative perception and more resistance to the use of generic medicines. The type of medical condition and its level of seriousness or severity, recommendations by health care professionals, price difference (ie, cost saving), previous experience of generic medicines, and knowledge/information about generic medicines were considered to be important factors that affect a patient's decision to use a generic medicine or a brand medicine. Conclusion:The results from this literature search show that patients and medicine consumers tend to prefer original brand medicines over generic medicines. Further, in many countries, there is still a considerable proportion of patients and consumers who lack adequate knowledge or have insufficient information about generic medicines. Thus, there is a need for educational interventions and activities to educate patients about generic medicines. It is also evident in the literature that health care professionals (physicians and pharmacists) play a key role in the promotion of generic medicines and in patients' acceptance of generic medicines and generic substitution. Hence, health care professionals need to play a more act...

show abstract

Why people refuse generic substitution: a population survey of public opinion on generic substitution in Finland

Cited by 5 publications

References 8 publications

Generic substitution in Finland: lessons learned during 2003-2008

Generic substitution in Finland: lessons learned during 2003-2008

Predictors of generic substitution: The role of psychological, sociodemographic, and contextual factors

Patient knowledge, perceptions, and acceptance of generic medicines: a comprehensive review of the current literature

Contact Info

Product

Resources

About